| Treatment groups |
Baseline TNSS |
TNSS at the end of 2-week study |
Mean change from baseline |
Mean percentage change from baseline |
Statistical analysis |
| Group A (Levocetirizine 5 mg) |
7.37 ± 0.93 |
4.96 ± 0.90 |
-2.41 ± 0.80 |
- 32.7% |
p<0.001, highly significant |
| Group B (Desloratidine 5 mg) |
7.11 ± 1.16 |
5.37 ± 0.79 |
-1.74 ± 0.80 |
- 24.5% |
p<0.001, highly significant |
